Literature DB >> 10365937

Treatment of cutaneous lymphoid hyperplasia with thalidomide: report of two cases.

H Benchikhi1, C Bodemer, S Fraitag, J Wechsler, M H Delfau-Larue, N Gounod, Y de Prost, J Revuz, M Bagot.   

Abstract

Cutaneous benign lymphoid hyperplasia is a B-cell pseudolymphoma of unknown origin. The most favored sites of involvement include the face. We report two cases involving the nose that showed complete and stable regression after a 2-month treatment course with thalidomide.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10365937     DOI: 10.1016/s0190-9622(99)70094-0

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

1.  Radiotherapy in aggressive cutaneous pseudolymphoma: a case report and review of literature.

Authors:  Deepa Joseph; Monica Malik Irukulla; Syed Fayaz Ahmed; Deepthi Valiyaveettil; Syed Akram
Journal:  Radiat Oncol J       Date:  2016-03-30

2.  Sustained remission of recalcitrant cutaneous lymphoid hyperplasia after thalidomide treatment.

Authors:  Stephen P Erickson; Zachary Nahmias; Ilana S Rosman; Kara Sternhell-Blackwell; Amy C Musiek
Journal:  JAAD Case Rep       Date:  2018-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.